Description

Lorazepam HF 2.5 mg

Lorazepam HF 2.5 mg is a prescription medicine manufactured by Hemofarm. It contains 2.5 mg of lorazepam, a benzodiazepine that is used for the short-term treatment of severe anxiety disorders and anxiety-related insomnia. It may also be prescribed as a premedication before certain medical, dental, or surgical procedures.

Active Ingredient

• Lorazepam 2.5 mg per tablet

Pharmaceutical Form

Lorazepam HF 2.5 mg is supplied as a blue, round tablet with a score line, allowing it to be divided into equal doses when required.

Mechanism of Action

Lorazepam acts on the central nervous system by enhancing the effects of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. This action produces anxiolytic, sedative, muscle-relaxant, and anticonvulsant effects.

Therapeutic Indications

Lorazepam HF 2.5 mg is indicated for:

• Short-term treatment of severe anxiety disorders.
• Treatment of anxiety associated with insomnia.
• Premedication before dental procedures and surgical interventions.

Possible Side Effects

Common adverse effects may include:

• Drowsiness
• Sedation
• Dizziness
• Reduced concentration
• Memory impairment
• Muscle weakness

Warnings and Precautions

• Long-term use may lead to tolerance and dependence.
• Treatment should not be discontinued abruptly after prolonged use due to the risk of withdrawal symptoms.
• Alcohol and other central nervous system depressants may enhance the sedative effects of lorazepam.
• Patients should avoid driving or operating machinery if they experience drowsiness or impaired alertness.

Packaging

Lorazepam HF 2.5 mg is available in packs containing 20 tablets (two blister strips of 10 tablets each).

Manufacturer

Lorazepam HF 2.5 mg is manufactured by Hemofarm, a pharmaceutical company headquartered in Vršac.

Prescription Status

Lorazepam HF 2.5 mg is a prescription-only medicine and should be used under the supervision of a qualified healthcare professional. Treatment is generally limited to short-term use because of the potential for dependence and withdrawal symptoms.